1 |
Ovarian Clear Cell Adenofibroma of Low Malignant Potential Developing Into Clear Cell Adenocarcinoma.
62
|
Yin Z...Heller D
|
29551085 |
2018 |
2 |
Possible de novo clear cell carcinoma in the contralateral ovary 9 years after fertility-sparing surgery for Stage IA clear cell ovarian carcinoma.
62
|
Nishida K...Satoh T
|
31149470 |
2017 |
3 |
Mature cystic teratoma coexisting with clear-cell carcinoma in the ovary.
62
|
Shimura K...Okubo T
|
27987343 |
2017 |
4 |
Borderline Clear Cell Adenofibroma of the Ovary.
62
|
Kleebkaow P...Kietpeerakool C
|
28465851 |
2017 |
5 |
Clear cell carcinoma of the ovary: comparison of MR findings of histological subtypes.
62
|
Kato H...Matsuo M
|
27167231 |
2016 |
6 |
Yolk sac tumours of the female genital tract in older adults derive commonly from somatic epithelial neoplasms: somatically derived yolk sac tumours.
62
|
McNamee T...McCluggage WG
|
27334714 |
2016 |
7 |
Effect of ARID1A/BAF250a expression on carcinogenesis and clinicopathological factors in pure-type clear cell adenocarcinoma of the ovary.
62
|
Kato M...Furuya K
|
27699033 |
2016 |
8 |
Pathologic Findings in Prophylactic and Nonprophylactic Hysterectomy Specimens of Patients With Lynch Syndrome.
62
|
Bartosch C...Oliva E
|
27340747 |
2016 |
9 |
Napsin A is a specific marker for ovarian clear cell adenocarcinoma.
62
|
Yamashita Y...Takahashi S
|
24721826 |
2015 |
10 |
Clear cell adenocarcinoma arising from clear cell adenofibroma of the ovary: value of DWI and DCE-MRI.
62
|
Takeuchi M...Harada M
|
24172789 |
2013 |
11 |
Ovarian benign clear cell adenofibroma in a patient with premature ovarian failure after 8-year hormone replacement therapy.
62
|
Chen R...Zhang Y
|
23153077 |
2013 |
12 |
Clear cell carcinoma of the ovary: is there a role of histology-specific treatment?
62
|
Takano M...Sugiyama T
|
22655678 |
2012 |
13 |
Aberrant expression of the mammalian target of rapamycin, hypoxia-inducible factor-1α, and glucose transporter 1 in the development of ovarian clear-cell adenocarcinoma.
62
|
Kato M...Furuya K
|
22498943 |
2012 |
14 |
Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations.
62
|
Yamamoto S...Matsubara O
|
22157930 |
2012 |
15 |
Accumulative copy number increase of MET drives tumor development and histological progression in a subset of ovarian clear-cell adenocarcinomas.
62
|
Yamamoto S...Matsubara O
|
21983935 |
2012 |
16 |
Borderline clear cell adenofibroma of the ovary associated with ovarian endometriosis: a case report.
62
|
Vasilakaki T...Manoloudaki K
|
22611972 |
2012 |
17 |
PIK3CA mutations and loss of ARID1A protein expression are early events in the development of cystic ovarian clear cell adenocarcinoma.
62
|
Yamamoto S...Matsubara O
|
22120431 |
2012 |
18 |
Primary Ovarian Clear Cell Adenofibroma of Borderline Malignancy.
62
|
Cakir E...Nurkabul Z
|
28861185 |
2012 |
19 |
Pathogenesis of ovarian clear cell adenofibroma, atypical proliferative (borderline) tumor, and carcinoma: clinicopathologic features of tumors with endometriosis or adenofibromatous components support two related pathways of tumor development.
62
|
Zhao C...Barner R
|
21479128 |
2011 |
20 |
Borderline clear cell adenofibroma with extensive hemorrhagic necrosis.
62
|
Liu JL...Huang RH
|
20890073 |
2010 |
21 |
Aberrant expression of p27(Kip1)-interacting cell-cycle regulatory proteins in ovarian clear cell carcinomas and their precursors with special consideration of two distinct multistage clear cell carcinogenetic pathways.
62
|
Yamamoto S...Matsubara O
|
19855998 |
2009 |
22 |
An allelotype analysis indicating the presence of two distinct ovarian clear-cell carcinogenic pathways: endometriosis-associated pathway vs. clear-cell adenofibroma-associated pathway.
62
|
Yamamoto S...Matsubara O
|
19655165 |
2009 |
23 |
Clear-cell adenofibroma can be a clonal precursor for clear-cell adenocarcinoma of the ovary: a possible alternative ovarian clear-cell carcinogenic pathway.
62
|
Yamamoto S...Matsubara O
|
18600856 |
2008 |
24 |
Expression of platelet-derived growth factors and their receptors in ovarian clear-cell carcinoma and its putative precursors.
62
|
Yamamoto S...Matsubara O
|
18084257 |
2008 |
25 |
Benign clear cell adenofibroma of the ovary. A case report with literature review.
62
|
Pasaoglu O...Acikalin MF
|
17202822 |
2007 |
26 |
Unexpected gynecologic neoplasms in patients with proven or suspected BRCA-1 or -2 mutations: implications for gross examination, cytology, and clinical follow-up.
62
|
Agoff SN...Garcia RL
|
11812938 |
2002 |
27 |
Tubulocystic ovarian clear cell carcinoma with abundant fibrous stroma: malignant clear cell adenofibroma.
62
|
Chan YJ...Ling F
|
10645058 |
2000 |
28 |
A pregnant woman with clear cell adenocarcinoma of the ovary arising from endometriosis and with benign and borderline adenofibroma of the clear cell and endometrioid types.
62
|
Sugiyama T...Yakushiji M
|
9076421 |
1997 |
29 |
Ovarian clear cell adenofibroma of borderline malignancy. A case report.
62
|
Katsube Y...Fujiwara A
|
2793520 |
1989 |
30 |
Ovarian clear cell adenofibromatous tumors. Benign, of low malignant potential, and associated with invasive clear cell carcinoma.
62
|
Roth LM...Czernobilsky B
|
6692303 |
1984 |